GEODE CAPITAL MANAGEMENT, LLC - VBI VACCINES INC ownership

VBI VACCINES INC's ticker is VBIV and the CUSIP is 91822J103. A total of 127 filers reported holding VBI VACCINES INC in Q3 2021. The put-call ratio across all filers is 1.04 and the average weighting 0.0%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of VBI VACCINES INC
ValueSharesWeighting
Q1 2023$1,226,671
+80549.0%
3,896,669
+0.2%
0.00%
Q4 2022$1,521
-99.9%
3,890,366
-0.1%
0.00%
Q3 2022$2,749,000
-17.3%
3,896,177
-5.3%
0.00%
Q2 2022$3,326,000
-49.0%
4,114,208
+4.7%
0.00%
-100.0%
Q1 2022$6,523,000
-26.1%
3,929,576
+4.2%
0.00%0.0%
Q4 2021$8,821,000
-27.2%
3,769,902
-3.2%
0.00%
-50.0%
Q3 2021$12,116,000
-1.1%
3,896,078
+6.5%
0.00%0.0%
Q2 2021$12,251,000
+13.2%
3,657,182
+5.1%
0.00%0.0%
Q1 2021$10,823,000
+32.8%
3,480,327
+17.4%
0.00%
+100.0%
Q4 2020$8,151,000
+0.9%
2,964,194
+4.9%
0.00%
-50.0%
Q3 2020$8,079,000
-9.3%
2,825,251
-1.7%
0.00%0.0%
Q2 2020$8,910,000
+294.6%
2,874,272
+20.9%
0.00%
+100.0%
Q1 2020$2,258,000
-66.6%
2,377,000
-51.4%
0.00%0.0%
Q4 2019$6,756,000
+882.0%
4,895,696
+235.1%
0.00%
Q3 2019$688,000
-44.2%
1,460,776
+38.6%
0.00%
Q2 2019$1,232,000
+4.6%
1,053,663
+67.2%
0.00%
Q1 2019$1,178,000
-23.6%
630,098
-34.6%
0.00%
Q4 2018$1,542,000
+222.6%
963,774
+387.8%
0.00%
Q3 2018$478,000
+1.3%
197,593
+15.0%
0.00%
Q2 2018$472,000
+43.9%
171,805
+83.1%
0.00%
Q1 2018$328,000
-10.4%
93,852
+9.4%
0.00%
Q4 2017$366,000
+68.7%
85,803
+51.6%
0.00%
Q3 2017$217,000
-7.3%
56,591
+4.8%
0.00%
Q2 2017$234,000
+90.2%
53,980
+140.3%
0.00%
Q1 2017$123,000
+132.1%
22,468
+31.0%
0.00%
Q4 2016$53,000
-7.0%
17,151
+3.7%
0.00%
Q3 2016$57,00016,5350.00%
Other shareholders
VBI VACCINES INC shareholders Q3 2021
NameSharesValueWeighting ↓
Perceptive Advisors 55,042,465$171,182,0002.49%
GENERAL AMERICAN INVESTORS CO INC 1,877,497$5,839,0000.50%
HighVista Strategies LLC 41,271$129,0000.08%
ArchPoint Investors 65,000$202,0000.06%
FIRST MIDWEST BANK TRUST DIVISION 136,714$425,0000.06%
FNY Investment Advisers, LLC 24,683$76,0000.04%
GRIMES & COMPANY, INC. 257,960$802,0000.04%
Cambridge Investment Research Advisors, Inc. 2,065,953$6,425,0000.03%
Ergoteles LLC 171,127$532,0000.02%
J.W. COLE ADVISORS, INC. 71,100$221,0000.02%
View complete list of VBI VACCINES INC shareholders